Lineará
Regenerative & CytoprotectiveOpen access · public

ACE-031

ACE-031, also known by the International Nonproprietary Name ramatercept, is a recombinant fusion protein listed as a reference material.

CAS 1169766-01-1UniProt Q13705Type ProteinResearch Use Only · reference

Identity & structure

ACE-031 — identity and specification
Identity
TypeProtein
Also known asRamatercept, ActRIIB-Fc, ActRIIB-IgG1 Fc fusion, ACVR2B-Fc, Soluble activin receptor type IIB, ACE031, ACE 031
CAS1169766-01-1
PubChem CIDNot assigned — a protein of this size receives no small-molecule PubChem CID
UniProtQ13705 — parent receptor - human ACVR2B (ActRIIB); ACE-031 uses its extracellular domain
Research classRegenerative & Cytoprotective
Structure
LengthHomodimer of ActRIIB extracellular-domain–human IgG1 Fc monomers
Molecular formulaNot applicable — glycoprotein; mass heterogeneous
InChIKeyNot assigned — proteins are outside InChI’s practical domain
PDB (proxy)1S4Y, 1NYS
Analytical
Monoisotopic massNot applicable — glycoprotein; mass heterogeneous

Mass basis (glycoprotein — no single exact mass)

  • Disulfide-linked homodimer, polypeptide basis (approx.)~76 kDa (about 38 kDa per monomer)
  • Glycosylated protein (SDS-PAGE apparent)higher and heterogeneous

ACE-031 is a glycosylated Fc-fusion homodimer, not a single fully-specified covalent molecule: like Follistatin-344 in this reference set, its glycans are heterogeneous, so no single molecular formula, exact mass, monoisotopic mass, or InChIKey applies and none is computed. Identity is carried by the construct (ActRIIB extracellular domain fused to a human IgG1 Fc), the parent-receptor UniProt entry Q13705, and representative ActRIIB extracellular-domain structures in the Protein Data Bank (1S4Y, 1NYS), shown as labelled proxies rather than structures of ACE-031 itself. The CAS Registry Number 1169766-01-1 and UNII 42HQC6QLEK correspond to ramatercept; a different registry number circulated by some vendors denotes a distinct, much smaller molecule and is not this entity. ACE-031 is kept distinct from sotatercept (ACE-011, activin receptor type IIA), luspatercept (ACE-536) and bimagrumab.

Reference context

ACE-031, also known by the International Nonproprietary Name ramatercept, is a recombinant fusion protein listed as a reference material. It is built from two defined parts: the extracellular (ligand-binding) domain of human activin receptor type IIB (ActRIIB, gene ACVR2B, UniProt Q13705) fused to the Fc region of human immunoglobulin G1 (IgG1). The IgG1 Fc drives assembly into a disulfide-linked homodimer, giving the molecule its antibody-like architecture - the reason it is often written ActRIIB-Fc. According to peer-reviewed literature indexed in PubMed, ACE-031 was described by researchers at Acceleron Pharma as a soluble form of activin receptor type IIB (Attie et al., Muscle & Nerve, 2013; Cadena et al., J Appl Physiol, 2010) - a statement of molecular identity only. Because it is a glycosylated Fc-fusion, its mass is heterogeneous and no single molecular formula or exact mass applies; the disulfide-linked homodimer is on the order of 76 kDa on a polypeptide basis (about 38 kDa per monomer), with the glycosylated protein running higher and heterogeneously. Lineará lists ACE-031 as a characterization-only reference entity, distinct from the related soluble activin type IIA fusion sotatercept (ACE-011). For Research Use Only - not for human or veterinary use.

Listed solely as a characterized analytical reference — no representation is made as to any biological effect. For Research Use Only — not for human or veterinary use.

How ACE-031 is characterized

For a folded protein, identity rests on the amino-acid sequence and its cross-references rather than a small-molecule structure. The sequence above is the anchor identifier; the UniProt accession and the representative Protein Data Bank entries locate the fold. Because the native protein is glycosylated, its mass is heterogeneous: it is stated as a labeled basis (calculated polypeptide mass and apparent mass by SDS-PAGE), not a single number, and no single molecular formula or monoisotopic mass applies.

IdentityAmino-acid sequence · UniProt Q13705
StructurePDB ribbon (proxy) · 1S4Y, 1NYS
MassBasis/range · glycoprotein

Frequently asked questions

What is ACE-031?
ACE-031 (INN ramatercept) is a recombinant fusion protein consisting of the extracellular domain of human activin receptor type IIB (ActRIIB) fused to the Fc region of human immunoglobulin G1 (IgG1). The Fc drives it to assemble into a disulfide-linked homodimer, so it is often written ActRIIB-Fc. It is a protein, not a short peptide.
Is ACE-031 a peptide or a protein?
ACE-031 is a protein - specifically a glycosylated antibody-Fc fusion protein (an Fc-fusion). It is far larger and more complex than a synthetic peptide, and it is characterized by its construct and its parent receptor rather than by a single small-molecule structure.
What is the molecular weight and formula of ACE-031?
Because ACE-031 is a glycosylated fusion protein, its mass is heterogeneous and no single exact molecular formula applies. On a polypeptide basis the disulfide-linked homodimer is on the order of 76 kDa (about 38 kDa per monomer), with the glycosylated protein running higher on SDS-PAGE. These figures are approximate.
What receptor is ACE-031 based on?
ACE-031 is based on activin receptor type IIB, encoded by the human gene ACVR2B (UniProt Q13705). It uses the receptor's extracellular ligand-binding domain, fused to an IgG1 Fc.
Does ACE-031 have a PubChem CID or InChIKey?
No. Proteins of this size - and glycosylated fusion proteins in particular - are not assigned small-molecule PubChem Compound IDs or InChIKeys. The appropriate identifiers are the construct description, the parent UniProt entry (Q13705), and representative ActRIIB structures in the Protein Data Bank.
How is ACE-031 different from sotatercept (ACE-011)?
ACE-031 (ramatercept) is built from activin receptor type IIB (ActRIIB), whereas sotatercept (ACE-011) is built from activin receptor type IIA (ActRIIA). Both are soluble activin-receptor Fc-fusion proteins, but they are based on different receptors and are distinct molecular entities.
How is ACE-031 stored and reconstituted?
As a research material, ACE-031 is typically handled as a lyophilized (freeze-dried) powder. It is kept desiccated and cold — commonly 2–8 °C for short periods and −20 °C for longer storage — and reconstituted in sterile or bacteriostatic water. This is storage and handling information only, not a use protocol.
Does Lineará sell ACE-031?
No. ACE-031 is listed here only as a characterization reference entity. It is not part of the Lineará formulary, has no price or certificate of analysis, and is not offered for sale.
Is ACE-031 approved for human use?
No. ACE-031 is presented strictly as characterization reference data. It is not a drug, is not approved for any human or veterinary use, and must not be administered to humans or animals.

Data, tools & related references

References

  1. UniProt — protein sequence & annotation (Q13705). UniProt →
  2. RCSB Protein Data Bank — representative structures (1S4Y, 1NYS).
  3. CAS Registry Number 1169766-01-1.

Research professionals only

Reference data

This monograph is characterization reference data. Lineará does not sell, stock, or certify ACE-031.

áFor Research Use Only · Not for human or veterinary use · Not for diagnostic or therapeutic use